Desh Rakshak Aushdhalaya Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 351394,
    "name": "Desh Rakshak",
    "stock_name": "Desh Rakshak",
    "full_name": "Desh Rakshak Aushdhalaya Ltd",
    "name_url": "stocks-analysis/desh-rakshak",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "32.00",
    "mcapval": "18.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531521,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE971E01016",
    "curr_date": "Jan 16",
    "curr_time": "",
    "bse_nse_vol": "300 ",
    "exc_status": "Active",
    "traded_date": "Jan 16, 2026",
    "traded_date_str": "2026 01 16",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/desh-rakshak-351394-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3746838",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DeshRakshakAush_only_sellers_3746838.png",
        "date": "2025-12-04 13:41:33",
        "description": "Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.86% today and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market benchmarks."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Sees Unprecedented Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-hits-upper-circuit-amidst-unprecedented-buying-interest-3735827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_buyers_3735827.png",
        "date": "2025-11-28 15:15:49",
        "description": "Desh Rakshak Aushdhalaya Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand amid a backdrop of mixed performance metrics over various time frames."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3731118",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3731118.png",
        "date": "2025-11-26 10:10:31",
        "description": "Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing severe selling pressure with no buyers in the queue, signalling distress selling and a notable shift in market sentiment. The stock has recorded consecutive declines over the past four days, reflecting a challenging phase for investors amid a broader market context."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Sees Extraordinary Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-unprecedented-buying-interest-amidst-price-decline-3730812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_buyers_3730812.png",
        "date": "2025-11-26 09:50:35",
        "description": "Desh Rakshak Aushdhalaya Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3728104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3728104.png",
        "date": "2025-11-25 09:40:40",
        "description": "Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, registering a sharp decline over the past week with no buyers visible in the order book. The stock’s performance contrasts starkly with broader market trends, signalling distress selling and heightened investor caution."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3725368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3725368.png",
        "date": "2025-11-24 11:30:32",
        "description": "Desh Rakshak Aushdhalaya Ltd experienced a pronounced decline in trading activity today, marked by exclusive selling interest and a sharp drop in its share price. The stock opened sharply lower and remained at its intraday low throughout the session, signalling distress selling and a lack of buyer support in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Desh Rakshak overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-desh-rakshak-overvalued-or-undervalued-3723547",
        "imagepath": "",
        "date": "2025-11-24 08:09:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Desh Rakshak’s Current Valuation Metrics</strong></p>\n<p>As of 21 Nov 2025, Desh Rakshak’s valuation grade was revised to fair, reflecting a more balanced assessment compared to its previous expensive rating. The company’s price-to-earnings (PE) ratio stands at 37.17, which is relatively high but not uncommon in the pharmaceutical industry, where growth prospects often justify premium multiples. The price-to-book (P/B) ratio of 1.90 suggests the stock is trading at nearly twice its book value, indicating moderate investor confidence in its asset base and future earnings potential.</p>\n<p>Enterprise value multiples further support this fair valuation stance. The EV to EBIT ratio is 23.04, while EV to EBITDA is 14.92, both figures signalling a valuation that is elevated but not e..."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Sharp Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3720170",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3720170.png",
        "date": "2025-11-21 09:50:25",
        "description": "Desh Rakshak Aushdhalaya Ltd experienced a pronounced downturn on 21 Nov 2025, marked by exclusive selling activity and a significant drop in its share price. The stock’s performance today starkly contrasts with broader market trends, signalling distress selling and heightened investor caution within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Hits Upper Circuit Amidst Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-hits-upper-circuit-amidst-unprecedented-buying-frenzy-3717376",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_buyers_3717376.png",
        "date": "2025-11-20 09:40:46",
        "description": "Desh Rakshak Aushdhalaya Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This surge reflects a strong demand in the Pharmaceuticals & Biotechnology sector, with the stock showing a remarkable streak of consecutive gains and a potential for a multi-day circuit scenario."
      }
    ],
    "total": 188,
    "sid": "351394",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/desh-rakshak-aushdhalaya-351394"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jan-2026",
      "details": "The Company hereby submit Confirmation Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "12-Jan-2026",
      "details": "The Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ruchika Chaturvedi & Navneet Chaturvedi",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Revised Disclosure Under Regulation 29(1) Of The Securities And Exchange Board Of India (SEBI) (Substantial Acquisition Of Shares And Takeovers) Regulations 2011",
      "datetime": "10-Jan-2026",
      "details": "The Company hereby submit revised disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 pursuant to discrepancy observed in the disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 submitted on September 10 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses

2025-12-04 13:41:33

Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.86% today and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market benchmarks.

Desh Rakshak Aushdhalaya Sees Unprecedented Buying Interest Amid Upper Circuit Scenario

2025-11-28 15:15:49

Desh Rakshak Aushdhalaya Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand amid a backdrop of mixed performance metrics over various time frames.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-26 10:10:31

Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing severe selling pressure with no buyers in the queue, signalling distress selling and a notable shift in market sentiment. The stock has recorded consecutive declines over the past four days, reflecting a challenging phase for investors amid a broader market context.

Desh Rakshak Aushdhalaya Sees Extraordinary Buying Interest Amid Upper Circuit Scenario

2025-11-26 09:50:35

Desh Rakshak Aushdhalaya Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 09:40:40

Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, registering a sharp decline over the past week with no buyers visible in the order book. The stock’s performance contrasts starkly with broader market trends, signalling distress selling and heightened investor caution.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-24 11:30:32

Desh Rakshak Aushdhalaya Ltd experienced a pronounced decline in trading activity today, marked by exclusive selling interest and a sharp drop in its share price. The stock opened sharply lower and remained at its intraday low throughout the session, signalling distress selling and a lack of buyer support in the Pharmaceuticals & Biotechnology sector.

Is Desh Rakshak overvalued or undervalued?

2025-11-24 08:09:52

Understanding Desh Rakshak’s Current Valuation Metrics As of 21 Nov 2025, Desh Rakshak’s valuation grade was revised to fair, reflecting a more balanced assessment compared to its previous expensive rating. The company’s price-to-earnings (PE) ratio stands at 37.17, which is relatively high but not uncommon in the pharmaceutical industry, where growth prospects often justify premium multiples. The price-to-book (P/B) ratio of 1.90 suggests the stock is trading at nearly twice its book value, indicating moderate investor confidence in its asset base and future earnings potential. Enterprise value multiples further support this fair valuation stance. The EV to EBIT ratio is 23.04, while EV to EBITDA is 14.92, both figures signalling a valuation that is elevated but not e...

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Sharp Decline

2025-11-21 09:50:25

Desh Rakshak Aushdhalaya Ltd experienced a pronounced downturn on 21 Nov 2025, marked by exclusive selling activity and a significant drop in its share price. The stock’s performance today starkly contrasts with broader market trends, signalling distress selling and heightened investor caution within the Pharmaceuticals & Biotechnology sector.

Desh Rakshak Aushdhalaya Hits Upper Circuit Amidst Unprecedented Buying Interest

2025-11-20 09:40:46

Desh Rakshak Aushdhalaya Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This surge reflects a strong demand in the Pharmaceuticals & Biotechnology sector, with the stock showing a remarkable streak of consecutive gains and a potential for a multi-day circuit scenario.

View All News